Date published:
Audience:
General public
The MRFF will provide almost $230 million for research into a range of health and medical issues that impact Australians. These include cardiovascular disease, cancer, dementia and cognitive decline, mental health and respiratory disease. Funding is from the MRFF’s:
- Clinical Trials Activity initiative ($6.5 million, 3 projects)
- Clinician Researchers initiative ($45.5 million, 33 projects)
- Early to Mid-Career Researchers initiative ($43.3 million, 26 projects)
- Medical Research Commercialisation initiative ($50 million, 1 project)
- Preventive and Public Health Research initiative ($47.9 million, 38 projects)
- Rapid Applied Research Translation initiative ($36.2 million, 9 projects).
Read the media release for information about these projects.
The MRFF will also provide $245 million under the following new grant opportunities:
- $99 million under the 2024 BioMedTech Incubator (guidelines are now available)
- $24 million under the 2024 Cardiovascular Health grant opportunity
- $44.8 million under the 2024 Early to Mid-Career Researchers grant opportunity
- $13.4 million under the 2024 Indigenous Health Research grant opportunity
- $23.7 million under the 2023 Innovative Trials grant opportunity
- $20 million under the 2024 Paediatric Brain Cancer Research grant opportunity
- $20 million under the 2024 Survivorship Care and Collaborative Research Prioritisation grant opportunity.
Visit GrantConnect and the MRFF grant opportunities calendar for details.
Learn more about the MRFF.